Selected research
Industry Research
Oxycodone Hydrochloride Capsules Industry Research Report 2026
Market perspective
The global Oxycodone Hydrochloride Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Oxycodone Hydrochloride Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Oxycodone Hydrochloride Capsules market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Oxycodone Hydrochloride Capsules market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Oxycodone Hydrochloride Capsules include NAPP PHARMACEUTICALS LIMITED, Allergan, Hikma Pharmaceuticals, Purdue Pharma, Sandoz, Zydus Cadila, Viatris, Lock Pharma and Teva Pharmaceuticals. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Oxycodone Hydrochloride Capsules market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Oxycodone Hydrochloride Capsules.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxycodone Hydrochloride Capsules Market by Company
NAPP PHARMACEUTICALS LIMITED
Allergan
Hikma Pharmaceuticals
Purdue Pharma
Sandoz
Zydus Cadila
Viatris
Lock Pharma
Teva Pharmaceuticals
Oxycodone Hydrochloride Capsules Segment by Type
5mg
10mg
20mg
Oxycodone Hydrochloride Capsules Segment by Application
Clinic
Hospital
Others
Oxycodone Hydrochloride Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oxycodone Hydrochloride Capsules companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
- 20mg
Applications
- Clinic
- Hospital
- Others
Companies covered
- NAPP PHARMACEUTICALS LIMITED
- Allergan
- Hikma Pharmaceuticals
- Purdue Pharma
- Sandoz
- Zydus Cadila
- Viatris
- Lock Pharma
- Teva Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oxycodone Hydrochloride Capsules by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 5mg
- 2.2.3 10mg
- 2.2.4 20mg
- 2.3 Oxycodone Hydrochloride Capsules by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinic
- 2.3.3 Hospital
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Oxycodone Hydrochloride Capsules Breakdown Data by Type
- 3.1 Global Oxycodone Hydrochloride Capsules Historic Market Size by Type (2021-2026)
- 3.2 Global Oxycodone Hydrochloride Capsules Forecasted Market Size by Type (2027-2032)
4 Oxycodone Hydrochloride Capsules Breakdown Data by Application
- 4.1 Global Oxycodone Hydrochloride Capsules Historic Market Size by Application (2021-2026)
- 4.2 Global Oxycodone Hydrochloride Capsules Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Oxycodone Hydrochloride Capsules Market Perspective (2021-2032)
- 5.2 Global Oxycodone Hydrochloride Capsules Growth Trends by Region
- 5.2.1 Global Oxycodone Hydrochloride Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Oxycodone Hydrochloride Capsules Historic Market Size by Region (2021-2026)
- 5.2.3 Oxycodone Hydrochloride Capsules Forecasted Market Size by Region (2027-2032)
- 5.3 Oxycodone Hydrochloride Capsules Market Dynamics
- 5.3.1 Oxycodone Hydrochloride Capsules Industry Trends
- 5.3.2 Oxycodone Hydrochloride Capsules Market Drivers
- 5.3.3 Oxycodone Hydrochloride Capsules Market Challenges
- 5.3.4 Oxycodone Hydrochloride Capsules Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Oxycodone Hydrochloride Capsules Players by Revenue
- 6.1.1 Global Top Oxycodone Hydrochloride Capsules Players by Revenue (2021-2026)
- 6.1.2 Global Oxycodone Hydrochloride Capsules Revenue Market Share by Players (2021-2026)
- 6.2 Global Oxycodone Hydrochloride Capsules Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Oxycodone Hydrochloride Capsules Head Office and Area Served
- 6.4 Global Oxycodone Hydrochloride Capsules Players, Product Type & Application
- 6.5 Global Oxycodone Hydrochloride Capsules Manufacturers Established Date
- 6.6 Global Oxycodone Hydrochloride Capsules Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 7.2 North America Oxycodone Hydrochloride Capsules Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 7.4 North America Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 8.2 Europe Oxycodone Hydrochloride Capsules Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 8.4 Europe Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 9.2 Asia-Pacific Oxycodone Hydrochloride Capsules Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 10.2 South America Oxycodone Hydrochloride Capsules Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 10.4 South America Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 11.2 Middle East & Africa Oxycodone Hydrochloride Capsules Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 NAPP PHARMACEUTICALS LIMITED
- 12.1.1 NAPP PHARMACEUTICALS LIMITED Company Information
- 12.1.2 NAPP PHARMACEUTICALS LIMITED Business Overview
- 12.1.3 NAPP PHARMACEUTICALS LIMITED Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.1.4 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Capsules Product Portfolio
- 12.1.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
- 12.2 Allergan
- 12.2.1 Allergan Company Information
- 12.2.2 Allergan Business Overview
- 12.2.3 Allergan Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.2.4 Allergan Oxycodone Hydrochloride Capsules Product Portfolio
- 12.2.5 Allergan Recent Developments
- 12.3 Hikma Pharmaceuticals
- 12.3.1 Hikma Pharmaceuticals Company Information
- 12.3.2 Hikma Pharmaceuticals Business Overview
- 12.3.3 Hikma Pharmaceuticals Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.3.4 Hikma Pharmaceuticals Oxycodone Hydrochloride Capsules Product Portfolio
- 12.3.5 Hikma Pharmaceuticals Recent Developments
- 12.4 Purdue Pharma
- 12.4.1 Purdue Pharma Company Information
- 12.4.2 Purdue Pharma Business Overview
- 12.4.3 Purdue Pharma Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.4.4 Purdue Pharma Oxycodone Hydrochloride Capsules Product Portfolio
- 12.4.5 Purdue Pharma Recent Developments
- 12.5 Sandoz
- 12.5.1 Sandoz Company Information
- 12.5.2 Sandoz Business Overview
- 12.5.3 Sandoz Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.5.4 Sandoz Oxycodone Hydrochloride Capsules Product Portfolio
- 12.5.5 Sandoz Recent Developments
- 12.6 Zydus Cadila
- 12.6.1 Zydus Cadila Company Information
- 12.6.2 Zydus Cadila Business Overview
- 12.6.3 Zydus Cadila Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.6.4 Zydus Cadila Oxycodone Hydrochloride Capsules Product Portfolio
- 12.6.5 Zydus Cadila Recent Developments
- 12.7 Viatris
- 12.7.1 Viatris Company Information
- 12.7.2 Viatris Business Overview
- 12.7.3 Viatris Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.7.4 Viatris Oxycodone Hydrochloride Capsules Product Portfolio
- 12.7.5 Viatris Recent Developments
- 12.8 Lock Pharma
- 12.8.1 Lock Pharma Company Information
- 12.8.2 Lock Pharma Business Overview
- 12.8.3 Lock Pharma Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.8.4 Lock Pharma Oxycodone Hydrochloride Capsules Product Portfolio
- 12.8.5 Lock Pharma Recent Developments
- 12.9 Teva Pharmaceuticals
- 12.9.1 Teva Pharmaceuticals Company Information
- 12.9.2 Teva Pharmaceuticals Business Overview
- 12.9.3 Teva Pharmaceuticals Revenue in Oxycodone Hydrochloride Capsules Business (2021-2026)
- 12.9.4 Teva Pharmaceuticals Oxycodone Hydrochloride Capsules Product Portfolio
- 12.9.5 Teva Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst